Literature DB >> 8826848

Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells.

C Trân-Thang1, E Kruithof, H Lahm, W A Schuster, M Tada, B Sordat.   

Abstract

Inflammation may promote malignant invasion by enhancing cancer cell-associated proteolysis. Here we present the effect of inflammatory cytokines on the plasminogen activation system of eight human colon carcinoma cell lines. Tumour necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) increased in several, but not all, cell lines the production of urokinase-type plasminogen activator (uPA), tissue-type PA (tPA) and plasminogen activator inhibitor type 1 (PAI-1) as analysed by zymography, enzyme immunoassays and Northern analysis. Interleukin 6 (IL-6) had no effect. uPA receptor (uPAR) mRNA levels were also upregulated. However, each individual cell line responded differently following exposure to TNF-alpha or IL-1 beta. For example, there was a dose-dependent up-regulation of uPA and PAI-1 in SW 620 cells, whereas increased uPA production in SW 1116 cells was not accompanied by an increase in PAI-1. The TNF-alpha stimulatory effect was blocked by anti-TNF-alpha Fab fragments. All cell lines expressed both types of TNF receptor mRNAs, whereas no transcript for TNF-alpha, IL-1 beta, IL-6, IL-6 receptor or the IL-1 receptors was found. Our results demonstrate that TNF-alpha and IL-1 beta stimulate the plasminogen activation system in tumour cell but the responses differed even in cells derived from the same tissue origin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826848      PMCID: PMC2074720          DOI: 10.1038/bjc.1996.447

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  52 in total

1.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.

Authors:  K Imamura; D Spriggs; D Kufe
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.

Authors:  D H Perlmutter; C A Dinarello; P I Punsal; H R Colten
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

6.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.

Authors:  K Yamasaki; T Taga; Y Hirata; H Yawata; Y Kawanishi; B Seed; T Taniguchi; T Hirano; T Kishimoto
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

7.  Evidence for tumour necrosis factor/cachectin production in cancer.

Authors:  F Balkwill; R Osborne; F Burke; S Naylor; D Talbot; H Durbin; J Tavernier; W Fiers
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

8.  Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

Authors:  R R Schleef; M P Bevilacqua; M Sawdey; M A Gimbrone; D J Loskutoff
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

9.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.

Authors:  R L Medcalf; E K Kruithof; W D Schleuning
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  8 in total

1.  Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines.

Authors:  A Kido; S Krueger; C Haeckel; A Roessner
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

2.  Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α.

Authors:  Chenchen Feng; Ming Guan; Qiang Ding; Yuanfang Zhang; Haowen Jiang; Hui Wen; Paohsun Wang; Zhong Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

3.  Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C.

Authors:  Lisa Pleyer; Philip Went; Gudrun Russ; Erika Prinz; Viktoria Faber; Hans-Joachim Röwert; Renate Karlbauer; Richard Greil
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.

Authors:  Silke Aldrian; Ingela Kindas-Mügge; Franz Trautinger; Ilse Fröhlich; Andrea Gsur; Irene Herbacek; Walter Berger; Michael Micksche
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

5.  Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, WXC-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases.

Authors:  S D Killeen; E J Andrews; J H Wang; T Wu; W Schmalix; B Muehlenweg; H P Redmond
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

Review 6.  Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.

Authors:  Susanna Wl de Geus; Victor M Baart; Martin C Boonstra; Peter Jk Kuppen; Hendrica Ajm Prevoo; Andrew P Mazar; Bert A Bonsing; Hans Morreau; Cornelis Jh van de Velde; Alexander L Vahrmeijer; Cornelis Fm Sier
Journal:  Biomark Insights       Date:  2017-06-22

7.  The pattern of cytokine gene expression in human colorectal carcinoma.

Authors:  Anna Csiszár; Tamás Szentes; Bea Haraszti; Annamária Balázs; Gyôzô G Petrányi; Eva Pócsik
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

8.  Signature Evaluation Tool (SET): a Java-based tool to evaluate and visualize the sample discrimination abilities of gene expression signatures.

Authors:  Chih-Hung Jen; Tsun-Po Yang; Chien-Yi Tung; Shu-Han Su; Chi-Hung Lin; Ming-Ta Hsu; Hsei-Wei Wang
Journal:  BMC Bioinformatics       Date:  2008-01-28       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.